In a statement Novartis AG said, it has launched a new share buyback of up to $15 billion which will end by 2023. Confirming an expected sales growth by 4% through 2026, the Swiss pharma giant said its capital allocation strategy… Read More ›
pharma
Pfizer Inc sells Chinese biosimilar assets to XuXi Biologics Inc
On Wednesday, in a statement Pfizer Inc said, it has decided to stop producing biosimilar products in China; it has also decided to sell one of its business unit in the eastern city of Hangzhou to WuXi Biologics Inc. “The… Read More ›
Amsterdam’s Schiphol Airport gears up chilled warehouses for COVID19 vaccine storage, transportation
In a significant development, Amsterdam’s Schiphol Airport stated, its workers are gearing up for a surge in the storing of COVID-19 vaccine cargos, which will be flown around the world at ultra-low temperatures. To that end, it has prepared its… Read More ›
Buyout giant Carlyle Group Inc close to purchasing Siemen’s mechanical drive arm Flender for $2.37 billion
According to a report from Bloomberg News, U.S. buyout group Carlyle Group Inc is closing in on a deal to acquire Siemens AG’s mechanical drive arm Flender for around $2.37 billion (2 billion euros). A deal could potentially be announced later this… Read More ›
Pfizer Inc to acquire Array Biopharma Inc for $10.64 billion
The deal will not only add to Pfizer’s EPS, but will also provide to stronger traction in the cancer drugs market. U.S. pharmaceutical giant Pfizer Inc stated it would acquire Array Biopharma Inc for $10.64 billion in cash. The potential… Read More ›
Cigna Corp overpaying for acquiring Express Scripts Holding Co: Carl Icahn
The deal, as pointed out by Carl Icahn’s letter to Cigna’s shareholders, has at least two significant areas of concern. On Tuesday, billionaire investor Carl Icahn urged Cigna Corp’s shareholders to vote against Cigna’s $52 billion acquisition of Express Scripts… Read More ›
Swiss pharmaceutical giant Novartis to divest its Alcon eye care devices business
The move is aimed at sharpening it focus on its prescription drugs business. On Friday, Novartis disclosed its plans of divesting all of its assets from its Alcon eye care devices business as it sharpens its focus on prescription drugs…. Read More ›
Boehringer Ingelheim and Sanofi agrees to divesture proposals to streamline their deal
Without this divesture, there is likely to be reduced competition among vaccine manufacturers in the U.S. and EU. The divesture is key to their $13.5 billion deal. So as to streamline Boehringer Ingelheim acquisition of Sanofi, the German pharmaceutical maker… Read More ›
manageria.biz 